No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Gardasil is a cancer vaccine developed by Merck & Co. and approved by the U.S. Food and Drug Administration (FDA) in 2006. It is used to prevent certain types of cancers caused by the human papillomavirus (HPV). Gardasil is the only HPV vaccine available in the United States and is recommended for both boys and girls aged 9 to 26. The vaccine is administered in three doses over a six-month period.
Gardasil is part of a larger market of cancer vaccines, which are designed to prevent or treat certain types of cancer. These vaccines are typically made from weakened or killed versions of the virus that causes the cancer, and are administered to individuals to help their bodies build immunity to the virus. Cancer vaccines are used to prevent or treat a variety of cancers, including cervical, head and neck, and liver cancers.
The Gardasil market is highly competitive, with several companies offering similar products. These include GlaxoSmithKline, Sanofi Pasteur, and Pfizer. Other companies, such as CSL Limited and Merck KGaA, also offer HPV vaccines. Show Less Read more
